We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.53B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+28.94%
3 Year Est. Return
+83.96%
5 Year Est. Return
+104.85%
10 Year Est. Return
+351.46%
AUM
$1.51B
AUM Growth
+$9.99M
(+0.66%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,417
New
217
Increased
264
Reduced
441
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$5.65M |
| 2 |
Sprott Physical Gold and Silver Trust
CEF
|
+$4.05M |
| 3 |
JPMorgan Chase
JPM
|
+$1.44M |
| 4 |
Amgen
AMGN
|
+$1.41M |
| 5 |
Chubb
CB
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$2.97M |
| 2 |
Verizon
VZ
|
+$2.06M |
| 3 |
Wells Fargo
WFC
|
+$1.89M |
| 4 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.76M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 16.35% |
| 2 | Healthcare | 12.68% |
| 3 | Industrials | 12.5% |
| 4 | Technology | 11.98% |
| 5 | Consumer Staples | 11.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Welltower
WELL
$170B
| $7.57M | 0.5% |
101,059
+572
| +0.6% | +$41.8K |
|
52
Vanguard Dividend Appreciation ETF
VIG
$111B
| $7.39M | 0.49% |
79,732
-8,077
| -9% | -$741K |
|
53
Meta Platforms (Facebook)
META
$1.66T
| $7.26M | 0.48% |
48,097
+8,033
| +20% | +$1.19M |
|
54
Cisco
CSCO
$431B
| $7.16M | 0.47% |
228,828
-18,593
| -8% | -$606K |
|
|
RTN
55
DELISTED
Raytheon Company
RTN
| $7.15M | 0.47% |
44,275
-3,433
| -7% | -$544K |
|
56
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.13M | 0.47% |
28
| – | – |
|
57
NextEra Energy
NEE
$173B
| $6.82M | 0.45% |
194,520
-320
| -0.2% | -$10.9K |
|
58
Alphabet (Google) Class C
GOOG
$4.02T
| $6.77M | 0.45% |
148,920
-1,760
| -1% | -$80.6K |
|
59
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.1B
| $6.75M | 0.45% |
21,245
-173
| -0.8% | -$54.5K |
|
60
Caterpillar
CAT
$376B
| $6.71M | 0.44% |
62,494
-4,188
| -6% | -$425K |
|
|
WBA
61
DELISTED
Walgreens Boots Alliance
WBA
| $6.71M | 0.44% |
85,759
-31
| -0% | -$2.55K |
|
62
ALPS Sector Dividend Dogs ETF
SDOG
$1.42B
| $6.61M | 0.44% |
154,932
-10,022
| -6% | -$427K |
|
|
AGN
63
DELISTED
Allergan plc
AGN
| $6.55M | 0.43% |
26,966
+351
| +1% | +$82.5K |
|
|
ESRX
64
DELISTED
Express Scripts Holding Company
ESRX
| $6.47M | 0.43% |
101,346
-4,884
| -5% | -$307K |
|
65
Comcast
CMCSA
$87.1B
| $6.47M | 0.43% |
166,135
-2,742
| -2% | -$108K |
|
66
Starbucks
SBUX
$115B
| $6.39M | 0.42% |
109,575
-1,572
| -1% | -$95.1K |
|
67
WisdomTree US SmallCap Dividend Fund
DES
$2.16B
| $6.34M | 0.42% |
236,550
-4,320
| -2% | -$116K |
|
68
Vanguard Morningstar Total Stock Market ETF
VTI
$686B
| $5.94M | 0.39% |
47,708
-971
| -2% | -$120K |
|
69
International Paper
IP
$18.5B
| $5.57M | 0.37% |
103,835
-645
| -0.6% | -$32.6K |
|
70
Kraft Heinz
KHC
$29.2B
| $5.56M | 0.37% |
64,940
-1,730
| -3% | -$157K |
|
71
US Bancorp
USB
$97B
| $5.56M | 0.37% |
107,071
+1,144
| +1% | +$58.9K |
|
72
Gilead Sciences
GILD
$181B
| $5.52M | 0.36% |
77,968
-8,939
| -10% | -$595K |
|
73
iShares Core S&P 500 ETF
IVV
$866B
| $5.49M | 0.36% |
22,553
+204
| +0.9% | +$49.2K |
|
74
General Mills
GIS
$19.9B
| $5.47M | 0.36% |
98,800
-623
| -0.6% | -$35.6K |
|
75
Thermo Fisher Scientific
TMO
$225B
| $5.32M | 0.35% |
30,473
+299
| +1% | +$50.2K |
|
Similar funds
GAM
BCL
IA
AFI
MC
SEIA
VAM
GCM
Central Trust Company's Q2 2017 Portfolio in Review
As of Q2 2017, Central Trust Company held 1,417 positions worth $1.51B, up 0.66% from $1.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Central Trust Company's Q2 2017 filing shows 217 new, 264 increased, 441 reduced and 109 closed positions. Its largest new stake was Abiomed Inc: 2,855 shares worth $409K. The largest sale was Xilinx Inc, an estimated $2.97M.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- Central Trust Company's largest Q2 2017 buy was Abiomed Inc: 2,855 shares worth $409K.
- Central Trust Company added most to iShares Gold Trust in Q2 2017, an estimated $5.65M increase.
- Central Trust Company's biggest Q2 2017 reduction was Xilinx Inc, cutting an estimated $2.97M.
- Central Trust Company fully exited Zayo Group Holdings, Inc. in Q2 2017, selling an estimated $91K.
- Central Trust Company's ten largest holdings make up 20% of its $1.51B portfolio in Q2 2017.
- Central Trust Company opened 217 new positions and closed 109 in Q2 2017.
- Central Trust Company's portfolio value rose 0.66% quarter-over-quarter to $1.51B.
Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.